PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.\', \'Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.\', \'Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.\', \'A\' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece.\', \'Intensive Care Unit, AHEPA University Hospital, Thessaloniki, Greece.\', \'Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece.\', \'National Peripheral Histocompatibility Center, Immunology Department, Hippokration General Hospital, Thessaloniki, Greece.\', \'Respiratory Failure Department, George Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.\', \'Department of Medicine, University of Washington, Seattle, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab371
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33905481
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all